tumor expansion trial

South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...

The Korea Trade-Investment Promotion Agency (KOTRA) announced on Wednesday the establishment of a South Korean pavilion at the upcoming SLUSH 2023, ...

Hancom Inc., a homegrown office suite developer in South Korea, is set to speed up its artificial intelligence business with a beta service of AI-po...

South Korea’s Kakao Mobility Corp. is expanding overseas services in the face of criticism over its business practices, including the alleged ...

South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...

BATAM – State-run Incheon International Airport Corp. (IIAC) is accelerating the growth of Hang Nadim International Airport in Batam, Indonesi...

South Korea's Lotte Home Shopping announced on Tuesday that it has displayed Bellygom Bellygom at Siam Discovery, the largest shopping mall in Bangk...

POSCO International Corp., the energy and trading unit of South Korea’s steel giant POSCO Holdings Inc., plans to spend 680 billion won ($519....

SK On Co., the battery-making affiliate of South Korea’s SK Group, has signed a deal to supply nickel-cobalt-manganese (NCM) battery cell modu...

South Korea's DGB Financial Group announced on Monday it signed a business agreement with the global IT company FPT Software at the FPT Group headqu...

South Korea’s web portal giant Naver Corp. on Friday posted record sales and operating profit in the third quarter, driven by robust sales gro...

SHANGHAI – E-Land World Ltd., a South Korean fashion and retail company, is gearing up for another leap forward in China, where the company&rs...

NKMax Co., South Korea's largest developer of natural killer (NK) cell therapies, will conduct its first clinical trials in the US for its candidate...

South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...

South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...

Mirae Asset Financial Group, South Korea’s leading financial conglomerate, on Monday promoted Swarup Mohanty, the head of its Indian asset man...

South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...

South Korean fashion commerce platform Ably Corp. announced on Wednesday its Japanese shopping platform amood starts a one-stop service for domestic...

South Korean chemical and auto parts maker KCC Corp. opened its first overseas refinish color center in the US. According to the company's anno...

Lotte Wellfood Co., formerly Lotte Confectionery Co., has revised up this year’s Choco Pie sales forecast in India to 80 billion won ($60 mill...

South Korean natural killer (NK) cell drugmaker NKMax Co. on Wednesday said its US subsidiary NKGen Biotech on Monday was listed on the Nasdaq Globa...

South Korea's JW Pharmaceutical Corp. on Thursday said it received approval from Thailand's Food and Drug Administration to conduct Phase 3 clinical...

Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...

BEIJING – Kakao Pay Corp., the mobile payment service unit of South Korean tech giant Kakao Corp., is rapidly growing in China’s fintech...

South Korea's Hyundai Engineering & Construction (E&C) will open a branch in Warsaw, Poland, to join a project to build small modular reacto...

South Korea's Daewoong Pharmaceutical is venturing into the development of a product that can easily treat diabetic retinopathy in the form of ...

South Korea has begun a pilot operation of a biofuel-powered container ship on a global route, the government said on Friday. HMM Co.'s container sh...

South Korea's VaxCell Biotherapeutics Co. on Tuesday said its treatment for advanced liver cancer under development stopped or greatly reduced the g...

Wellmarker Bio, South Korea's oncology drug development company, announced on Monday that it has signed a technology transfer agreement with a Europ...

South Korean clinical-stage biotech company AriBio Co. on Thursday said it applied for Phase 3 clinical trials on the anti-Alzheimer's candidate t...